Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.78
-0.0500-2.73%
Post-market: 1.830.0500+2.81%14:00 EDT
Volume:97.07K
Turnover:174.45K
Market Cap:12.30M
PE:-0.74
High:1.85
Open:1.84
Low:1.75
Close:1.83
Loading ...

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

GlobeNewswire
·
27 Mar

BRIEF-Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge

Reuters
·
26 Mar

Intelligent Bio Solutions Inc - Granted U.S. Patent for Fingerprinting Drug Screening Cartridge

THOMSON REUTERS
·
26 Mar

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

GlobeNewswire
·
26 Mar

Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch

THOMSON REUTERS
·
25 Mar

EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch

Benzinga
·
25 Mar

Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology

MT Newswires Live
·
20 Mar

Intelligent Bio Solutions to Expand U.S. Ip Portfolio With Expected Patent Grant

THOMSON REUTERS
·
20 Mar

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

GlobeNewswire
·
20 Mar

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

GlobeNewswire
·
11 Mar

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock

GlobeNewswire
·
22 Feb

BRIEF-Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock

Reuters
·
20 Feb

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
20 Feb

Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024)

Simply Wall St.
·
15 Feb

Intelligent Bio Solutions Q2 EPS $(0.50) Up From $(2.07) YoY, Sales $607.49K Down From $764.06K YoY

Benzinga
·
13 Feb

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

THOMSON REUTERS
·
13 Feb

Intelligent Bio Solutions Q2 Basic EPS USD -0.5

THOMSON REUTERS
·
13 Feb

Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy

TIPRANKS
·
10 Feb

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

THOMSON REUTERS
·
10 Feb

Intelligent Bio says Avon selects Intelligent Fingerprinting Drug Testing tool

TIPRANKS
·
07 Feb